Figure 3.
CO inhibits pro-atherosclerotic processes. CO blocks the multifaceted signaling pathways related to atherosclerotic progress. This progress can include monocyte infiltration through adhesion molecules (i.e., ICAM-1 and VCAM-1), macrophage differentiation from monocytes, foam cell formation, and inflammatory cytokine releases and ONOO− production. Additionally, CO reduces EC apoptosis and SMC migration and proliferation. OxLDL, oxidized low-density lipoprotein; ICAM-1, intercellular adhesion molecule-1; VCAM-1, vascular cell adhesion molecule-1; TNF-α, tumor necrosis factor-α; IL-1β, interleukin-1β.